NYSE: GRDNGuardian Pharmacy Services Inc Stock
$19.69-0.57 (-2.81%)
Updated Jun 13, 2025
GRDN Price
$19.69
Fair Value Price
N/A
Market Cap
$1.25B
52 Week Low
$14.16
52 Week High
$26.91
P/E
N/A
P/B
7.98x
P/S
1.03x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.28B
Earnings
-$89.98M
Gross Margin
19.8%
Operating Margin
-6.15%
Profit Margin
-7%
Debt to Equity
1.09
Operating Cash Flow
N/A
Beta
0.76
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine GRDN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
GRDN
Ranked#18 of 42
Ranked#18 of 42
Be the first to know about important GRDN news, forecast changes, insider trades & much more!
GRDN News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how GRDN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
GRDN is poor value based on its book value relative to its share price (7.98x), compared to the US Medical Care Facilities industry average (4.55x)
P/B vs Industry Valuation
GRDN's profit margin has decreased (-9%) in the last year from (2%) to (-7%)
Profit Margin Growth Financials
GRDN's short-term assets ($166.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more GRDN due diligence checks available for Premium users.
Valuation
GRDN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
16.48x
Market
31.36x
GRDN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.98x
Industry
4.55x
GRDN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
GRDN's financial health
Profit margin
Revenue
$329.3M
Net Income
$9.4M
Profit Margin
2.9%
GRDN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$334.0M
Liabilities
$170.8M
Debt to equity
1.09
GRDN's short-term assets ($166.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GRDN's short-term assets ($166.04M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GRDN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$17.6M
Investing
-$5.5M
Financing
-$2.7M
GRDN vs Medical Care Facility Stocks
Guardian Pharmacy Services Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.